Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Veeva Systems Inc. (VEEV)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
207.04+7.12 (+3.56%)
At close: 04:07PM EDT
207.00 -0.04 (-0.02%)
After hours: 07:47PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close199.92
Open202.49
Bid205.50 x 800
Ask210.00 x 800
Day's Range201.11 - 207.29
52 Week Range152.04 - 343.96
Volume1,574,657
Avg. Volume1,117,504
Market Cap31.835B
Beta (5Y Monthly)0.78
PE Ratio (TTM)77.83
EPS (TTM)2.66
Earnings DateFeb 28, 2022 - Mar 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est260.56
  • Motley Fool

    These 2 Stocks Are Ready to Bounce, According to Wall Street

    Investors haven't been able to regain their equilibrium after a brutal start to 2022. Many opportunistic investors have been combing through the hard-hit stocks in the market to try to find good long-term candidates for a recovery. On Thursday, Wall Street analysts singled out Snowflake (NYSE: SNOW) and Veeva (NYSE: VEEV) as possible opportunities for bargain-hunters.

  • Zacks

    Veeva Systems (VEEV) Inks Deal to Serve Rare Disease Patients

    Adoption of Veeva Systems' (VEEV) cloud applications is likely to significantly boost its Veeva Development Cloud business.

  • PR Newswire

    ANI Pharmaceuticals Adopts Veeva Commercial Cloud to Better Support Rare Disease Patients

    ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) and Veeva Systems (NYSE: VEEV) today announced a collaboration to define and operationalize data-driven commercial strategies for ANI's new Rare Disease Business Unit. ANI is using software, data, and services from Veeva to establish the digital foundation for the launch of the business unit's first commercially available product in the U.S.

Advertisement
Advertisement